CTOs on the Move

MPLN, Molecular Pathology Laboratory Network

www.mplnet.com

 
Personalized Molecular Pathology Laboratory Services Molecular Pathology Laboratory Network, Inc (MPLN) is a regional diagnostic laboratory specializing in oncology and women's health testing.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.mplnet.com
  • 250 E Broadway Ave
    Maryville, TN USA 37804
  • Phone: 865.380.9746

Executives

Name Title Contact Details

Similar Companies

Synergetics USA, Inc

Synergetics USA, Inc. (Synergetics USA) designs, manufactures and markets microsurgical instruments, medical capital equipment and other medical devices primarily for use in ophthalmic surgery and neurosurgical applications.

Autonomic Technologies

Welcome. Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company`s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache. The ATI Neurostimulation System was voted #2 among the Cleveland Clinic’s top 10 medical innovations for 2013, and Autonomic Technologies was named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device and diagnostics companies in the world.

US HealthConnect

US HealthConnect is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lantheus

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.

Laerdal Medical

Laerdal Medical Corporation maintains a national sales field team to assist customers with product information and demonstrations. Please use our contact form to request the name of your Laerdal Sales Representative.